ANDROGENETIC ALOPECIA (AGA)
Clinical trials for ANDROGENETIC ALOPECIA (AGA) explained in plain language.
Never miss a new study
Get alerted when new ANDROGENETIC ALOPECIA (AGA) trials appear
Sign up with your email to follow new studies for ANDROGENETIC ALOPECIA (AGA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial seeks to regrow hair in men with baldness
Disease control CompletedThis study tested an investigational drug called CG2001 to see if it could help regrow hair in men with male pattern baldness. It involved 110 Chinese men who applied the treatment or a placebo for 24 weeks. The main goal was to see if it increased hair count and thickness, and t…
Matched conditions: ANDROGENETIC ALOPECIA (AGA)
Phase: PHASE2 • Sponsor: Beijing Dayspring Pharmaceutical Technology Co., Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Could an eye drop ingredient help women regrow hair?
Disease control CompletedThis small, completed pilot study tested whether a cosmetic product containing latanoprost acid could improve hair growth in women with female pattern hair loss or chronic shedding. Twenty-nine women aged 18-60 applied one of three strengths of the product or a placebo to their s…
Matched conditions: ANDROGENETIC ALOPECIA (AGA)
Phase: NA • Sponsor: Medical University of Warsaw • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
Can a daily pill and drink slow hair thinning?
Symptom relief CompletedThis study tested whether a daily dietary supplement in capsule and drink form could help reduce hair loss. 240 men and women with common hair thinning conditions took either the supplement or a placebo for six months. Researchers measured changes in hair density and asked partic…
Matched conditions: ANDROGENETIC ALOPECIA (AGA)
Phase: NA • Sponsor: Lacer S.A. • Aim: Symptom relief
Last updated Mar 30, 2026 14:29 UTC